| Vaccine maker Pfizer and its German partner BioNTech on Thursday submitted a request to the Food and Drug Administration, seeking emergency use authorization for its mRNA vaccine for children age 5 to 11. If authorized, this would be the first coronavirus vaccine available to U.S. children younger than 12. | 
